(Q37404805)

20 August 2017

1 reference

title

Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy (English)

1 reference

cost-effectiveness analysis

20 August 2017

0 references

1 reference

1 reference

Alec B O'Connor

1

0 references

publication date

1 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

27

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

95-112

1 reference

Patient safety is not enough: targeting quality improvements to optimize the health of the population

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Diabetic peripheral neuropathy and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Psychological aspects of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec database

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Neuropathic pain: a practical guide for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Anticholinergic activity of two tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

The effects of antidepressants on obstructed and unobstructed gait in healthy elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927020-00002

Prevalence of chronic pain and its impact on health-related quality of life in stroke survivors

21 January 2018

1 reference

12 December 2020

Carpal tunnel syndrome, the search for a cost-effective surgical intervention: a randomised controlled trial

1 reference

12 December 2020

Economic evaluation of oral treatments for neuropathic pain

1 reference

12 December 2020

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

1 reference

12 December 2020

Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives

1 reference

12 December 2020

The economic burden of carpal tunnel syndrome: long-term earnings of CTS claimants in Washington State

1 reference

12 December 2020

Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community.

1 reference

12 December 2020

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

12 December 2020

The management of persistent pain in older persons

1 reference

12 December 2020

The impact of neuropathic pain on health-related quality of life: review and implications

1 reference

12 December 2020

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

12 December 2020

Symptoms, disability, and quality of life in patients with carpal tunnel syndrome.

1 reference

12 December 2020

Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin

1 reference

12 December 2020

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

1 reference

12 December 2020

Epidemiology and treatment of neuropathic pain: the UK primary care perspective

1 reference

12 December 2020

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

1 reference

12 December 2020

A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia

1 reference

12 December 2020

Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans

1 reference

12 December 2020

Cost benefit analysis of neurostimulation for chronic pain

1 reference

12 December 2020

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial

1 reference

12 December 2020

The burden of Herpes Zoster: a prospective population based study

1 reference

12 December 2020

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

1 reference

12 December 2020

Epidemiology of refractory neuropathic pain

1 reference

12 December 2020

EFNS guidelines on pharmacological treatment of neuropathic pain.

1 reference

12 December 2020

The social consequences for older people of neuropathic pain: a qualitative study.

1 reference

12 December 2020

1 reference

12 December 2020

Clinical characteristics and economic costs of patients with painful neuropathic disorders

1 reference

12 December 2020

Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns

1 reference

12 December 2020

Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study

1 reference

12 December 2020

Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings

1 reference

12 December 2020

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

1 reference

12 December 2020

A cost-utility comparison of four first-line medications in painful diabetic neuropathy

1 reference

12 December 2020

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

12 December 2020

Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia

1 reference

12 December 2020

Duloxetine vs. placebo in patients with painful diabetic neuropathy

1 reference

12 December 2020

1 reference

12 December 2020

Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions.

1 reference

12 December 2020

Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review

1 reference

12 December 2020

The cost of treatment for post-herpetic neuralgia in the UK

1 reference

12 December 2020

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

12 December 2020

Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.

1 reference

12 December 2020

Antiviral therapies for herpes zoster infections. Are they economically justifiable?

1 reference

12 December 2020

Pain coping strategies play a role in the persistence of pain in post-herpetic neuralgia

1 reference

12 December 2020

The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach

1 reference

12 December 2020

Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey

1 reference

12 December 2020

Spinal cord injury pain: the influence of psychologic factors and impact on quality of life.

1 reference

12 December 2020

Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain.

1 reference

12 December 2020

Endoscopic versus open carpal tunnel release: a cost-effectiveness analysis

1 reference

12 December 2020

Early outcome and cost-effectiveness of endoscopic versus open carpal tunnel release: a randomized prospective trial

1 reference

12 December 2020

Explicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly

1 reference

12 December 2020

Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial

1 reference

12 December 2020

Pain: moving from symptom control toward mechanism-specific pharmacologic management

1 reference

12 December 2020

Pharmacologic management of neuropathic pain: evidence-based recommendations

1 reference

12 December 2020

Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries

1 reference

12 December 2020

The burden of neuropathic pain: results from a cross-sectional survey.

1 reference

12 December 2020

Intrathecal opioids for intractable pain syndromes

1 reference

12 December 2020

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

1 reference

12 December 2020

A registry of the aetiology and costs of neuropathic pain in pain clinics : results of the registry of aetiologies and costs (REC) in neuropathic pain disorders study

1 reference

12 December 2020

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

12 December 2020

Carpal tunnel release in the United States and Sweden: reimbursement patterns, cost for treatment, and return to work

1 reference

12 December 2020

The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction?

1 reference

12 December 2020

A prospective cost-effectiveness study of trigeminal neuralgia surgery

1 reference

12 December 2020

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

1 reference

12 December 2020

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

1 reference

12 December 2020

Sequential medication strategies for postherpetic neuralgia: a cost-effectiveness analysis

1 reference

12 December 2020

Phantom pain and health-related quality of life in lower limb amputees

1 reference

12 December 2020

Oral opioid therapy for chronic peripheral and central neuropathic pain

1 reference

12 December 2020

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

1 reference

12 December 2020

Peripheral neuropathy in HIV disease

1 reference

12 December 2020

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

1 reference

12 December 2020

Use of tricyclic antidepressants in older patients with painful neuropathies

1 reference

12 December 2020

Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy

1 reference

12 December 2020

Pain associated with multiple sclerosis: systematic review and proposed classification

1 reference

12 December 2020

Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain

1 reference

12 December 2020

Bias in published cost effectiveness studies: systematic review

1 reference

12 December 2020

Rechargeable spinal cord stimulation versus non-rechargeable system for patients with failed back surgery syndrome: a cost-consequences analysis

1 reference

12 December 2020

Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom.

1 reference

12 December 2020

Carpal tunnel syndrome: cross-sectional and outcome study in Ontario workers

1 reference

12 December 2020

Healthcare Costs of Acute and Chronic Pain Associated with a Diagnosis of Herpes Zoster

1 reference

12 December 2020

Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective

1 reference

12 December 2020

EFNS guidelines on neurostimulation therapy for neuropathic pain

1 reference

12 December 2020

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

1 reference

12 December 2020

Peripheral neuropathic pain--a multidimensional burden for patients

1 reference

12 December 2020

A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia

1 reference

12 December 2020

Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep

1 reference

12 December 2020

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

1 reference

12 December 2020

Practice parameters for the use of spinal cord stimulation in the treatment of chronic neuropathic pain

1 reference

12 December 2020

The health care costs of diabetic peripheral neuropathy in the US.

1 reference

12 December 2020

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

1 reference

12 December 2020

Algorithm for neuropathic pain treatment: an evidence based proposal.

1 reference

12 December 2020

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials

1 reference

12 December 2020

1 reference

12 December 2020

Neuropathic pain: redefinition and a grading system for clinical and research purposes

1 reference

12 December 2020

Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study

1 reference

12 December 2020

Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states

1 reference

12 December 2020

Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen

1 reference

12 December 2020

Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression

1 reference

12 December 2020

The SF-6D health utility index in carpal tunnel syndrome

1 reference

12 December 2020

Surgery is more cost-effective than splinting for carpal tunnel syndrome in the Netherlands: results of an economic evaluation alongside a randomized controlled trial

1 reference

12 December 2020

Cost-benefit evaluation of spinal cord stimulation treatment for failed-back surgery syndrome patients

1 reference

12 December 2020

10.2165/00019053-200927020-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

20 August 2017

1010122381

0 references

1 reference